IMARC Group’s report titled “Genotyping Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028“, The global genotyping market size reached US$ 17.0 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 39.0 Billion by 2028, exhibiting a growth rate (CAGR) of 14.2% during 2023-2028.
Malathion is an organophosphate insecticide, a colorless liquid with a characteristic odor. It consists of a specific chemical structure that includes phosphorus, sulfur, and oxygen atoms. It is applied to crops like fruits, vegetables, and grains to protect them from harmful insects like aphids, thrips, and leafhoppers. It functions by inhibiting the activity of acetylcholinesterase, an enzyme critical for nerve signal transmission in insects. It is synthesized through a chemical process that involves several steps, including esterification, thionization, and purification. It is available in various formulations for different applications, such as liquid concentrates, dust, and aerosols. It is extensively used to manage pests like flies, mosquitoes, and cockroaches in households.
For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/genotyping-market/requestsample
Genotyping Market Trends and Drivers:
At present, the rising need for malathion in the agriculture sector to protect crops from a wide range of insects to ensure higher yields and better crop quality represents one of the crucial factors impelling the market growth. Additionally, the growing employment of malathion in public health programs to control disease-carrying vectors in regions prone to vector-borne diseases like malaria and Zika virus is positively influencing the market. Besides this, the increasing adoption of integrated pest management (IPM) practices in agriculture, which emphasize using multiple pest control methods, is driving the demand for malathion as a part of a comprehensive pest management approach. Moreover, ongoing research and development (R&D) efforts to improve the formulation and safety of malathion-based products are supporting the market growth. In addition, rising advancements in pesticide formulation technology, such as microencapsulation and controlled-release formulations, are enhancing the effectiveness and safety of malathion. Furthermore, the increasing need for effective pest control solutions like malathion due to changing pest patterns is contributing to the market growth. Apart from this, the easy application of malathion is making it an attractive choice for farmers and pest control operators.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Product and Service:
- Instruments
- Reagents and Kits
- Software and Services
Breakup by Technology:
- Polymerase Chain Reaction (PCR)
- Capillary Electrophoresis
- Microarray
- Sequencing
- Mass Spectrometry
- Others
Breakup by Application:
- Pharmacogenomics
- Diagnostics and Personalized Medicine
- Agricultural Biotechnology
- Animal Genetics
- Others
Breakup by End User:
- Pharmaceutical and Biopharmaceutical Companies
- Diagnostics and Research Laboratories
- Academic Institutes
- Others
Market Breakup by Region:
- North America (United States, Canada)
- Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America (Brazil, Mexico, Others)
- Middle East and Africa
Competitive Landscape with Key Player:
- Agilent Technologies Inc.
- Bio-Rad Laboratories Inc.
- Danaher Corporation
- Eurofins Scientific SE
- Hoffmann-La Roche AG
- Illumina Inc.
- Laboratory Corporation of America Holdings
- Qiagen N.V
- Standard BioTools Inc. and Thermo Fisher Scientific Inc.
If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Contact US
IMARC Group
Email: [email protected]
USA: +1-631-791-1145 | Asia: +91-120-433-0800
Address: 134 N 4th St. Brooklyn, NY 11249, USA
Follow us on Twitter: @imarcglobal